FundingHealthcare & Life Sciences
Redcliffe Labs raises $80 million for expansion
By Abha Lohia · Editor ·
Redcliffe Labs: revenue and funding and every story →
growth
- Redcliffe Labs is a diagnostics company with self-owned labs and home sample collection
- It raised $80 million to expand to 250 labs and 10,000 collection centres by 2025
- The company aims to go public in 2025-26 and expects to break even by end of 2023
What happened
- Redcliffe Labs raised $80 million for expansion.
- It plans to add 250 labs and 10,000 collection centres by 2025.
- Long-term target is 700 labs and 25,000 collection centres by 2027-28.
- The company aims to go public in 2025-26.
- Expansion focus is on Tier II, III, IV regions in UP, MP, Rajasthan, Bihar, Jharkhand, Chhattisgarh.
- It is also strengthening presence in Maharashtra and Gujarat.
- Redcliffe Labs is simplifying reports with AI technology and looking at specialised testing packages.
- It expects to break even by end of 2023.
Why it matters
- The diagnostics segment in India is doubling every 4.5 years.
- Redcliffe Labs has invested Rs 450 crore between 2020-23 in infrastructure.
- Current revenue is Rs 500 crore per annum.
- The company employs 3,000 people.
The business
- Redcliffe Labs is a diagnostics service provider with self-owned certified labs, home sample collection, smart reports, AI assistance, and diet plans.
- It offers health checkup packages for various conditions: fever, heart, vitamin, diabetes, thyroid, hormones, lifestyle, cancer, pregnancy, allergy, arthritis, STD, anemia, antenatal.
- It has sub-brands: Femcliffe (she-centric diagnostic platform), GeneCliffe (DNA insights), and HealthEx (curated tests by genetic experts).
- It guarantees 100% report accuracy or money-back.
- Website claims: 1 Crore+ lives touched, 80+ self-owned certified labs, 2,000+ collection centres, 1500+ trained phlebotomists.
The founders
DJ
Dheeraj Jain
Founder and MDIn numbers
81Current labs · 2023
2000+Current collection centres · 2023
Rs 500 croreRevenue per annum · 2023
3000Employees · 2023
Rs 450 croreInvestment in infrastructure (2020-23) · 2023
What happens next
- Add 250 labs and 10,000 collection centres by 2025.
- Reach 700 labs and 25,000 collection centres by 2027-28.
- Go public in 2025-26.
- Expand in Tier II, III, IV regions and strengthen presence in Maharashtra and Gujarat.
- Simplify reports with AI and introduce specialised testing packages.
The numbers around it
Redcliffe Labs has 4 funding rounds in StopDown's archive, $115 Mn raised in all.
| When | Round | Amount | Led by |
|---|---|---|---|
| 17 September 2024 | Series C | $42M | IFU (Denmark's Investment Fund for Developing Countries) |
| 29 September 2022 | Series B | $100-125 million | |
| 6 May 2022 | Series B | $61M | LeapFrog Investments |
Terms in this story
- Profitability: A path to profitability is the plan and evidence that a startup will earn more than it spends. In India the usual order is contribution positive, then EBITDA positive, then net profit and positive cash flow. Each step is a different test, so claims of profit need the definition.
Read next
FundingRedcliffe Lifetech raises $61 million Series BRedcliffe Lifetech is an omnichannel diagnostics platform offering 3,500+ pathology and genetic testsFundingAugust AI raises $12M for US expansionAugust AI offers an AI health assistant that answers medical questions through WhatsApp and a mobile appFundingVitusCare raises $3 million Series BVitusCare runs dialysis units inside partner hospitals, which keeps costs low, and has grown from 22 to over 60 centres
Everything on Redcliffe Labs → · All startup news on 13 August 2023 →
Is this Redcliffe Labs? Get your “Featured on StopDown” badge →